Toviaz label

Toviaz

Toviaz Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

Do not use

  • to make a child sleepy
  • with any other product containing diphenhydramine, even one used on skin 
Ask a doctor before use if you have

  • breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • trouble urinating due to an enlarged prostate gland 
Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers. 

When using this product

  • marked drowsiness may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery
  • excitability may occur, especially in children 
If pregnant or breast-feeding,

 ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away. 

Do not use

  • to make a child sleepy
  • with any other product containing diphenhydramine, even one used on skin 

Ask a doctor before use if you have

  • breathing problem such as emphysema or chronic bronchitis
  • glaucoma
  • trouble urinating due to an enlarged prostate gland 

Ask a doctor or pharmacist before use if you are

taking sedatives or tranquilizers. 

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

  • temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
    • runny nose
    • itchy, watery eyes
    • sneezing
    • itching of the nose or throat
  • temporarily relieves these symptoms due to the common cold:
    • runny nose
    • sneezing 
Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

There are no additional details available for this product.

Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Toviaz Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Toviaz Manufacturers

  • Cardinal Health
    Toviaz | Meijer
    No Recall

    Toviaz | Meijer

    Toviaz | Meijer
    take every 4 to 6 hours, or as directed by a doctor do not take more than 6 times in 24 hours  adults and children 12 
     years and over  1 to 2 tablets 
     children 6 to under 12
     years  1 tablet

     children under 6 years  do not use
  • Physicians Total Care, Inc.
    Toviaz | Physicians Total Care, Inc.
    No Recall

    Toviaz | Physicians Total Care, Inc.

    Toviaz | Physicians Total Care, Inc.

    The recommended starting dose of Toviaz is 4 mg once daily. Based upon individual response and tolerability, the dose may be increased to 8 mg once daily.

    The daily dose of Toviaz should not exceed 4 mg in the following populations:

    Patients with severe renal impairment (CLCR <30 mL/min). Patients taking potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin.

    Toviaz is not recommended for use in patients with severe hepatic impairment (Child-Pugh C) [see Warnings and Precautions (5.5, 5.7, 5.8); Use in Specific Populations (8.6, 8.7); and Drug Interactions (7.2)].

    Toviaz should be taken with liquid and swallowed whole. Toviaz can be administered with or without food, and should not be chewed, divided, or crushed.

  • Pfizer Laboratories Div Pfizer Inc
    Toviaz | Pfizer Laboratories Div Pfizer Inc
    No Recall

    Toviaz | Pfizer Laboratories Div Pfizer Inc

    Toviaz | Pfizer Laboratories Div Pfizer Inc

    The recommended starting dose of Toviaz is 4 mg once daily. Based upon individual response and tolerability, the dose may be increased to 8 mg once daily.

    The daily dose of Toviaz should not exceed 4 mg in the following populations:

    Patients with severe renal impairment (CLCR <30 mL/min). Patients taking potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin.

    Toviaz is not recommended for use in patients with severe hepatic impairment (Child-Pugh C) [see Warnings and Precautions (5.6, 5.8, 5.9); Use in Specific Populations (8.6, 8.7); and Drug Interactions (7.2)].

    Toviaz should be taken with liquid and swallowed whole. Toviaz can be administered with or without food, and should not be chewed, divided, or crushed.

  • U.s. Pharmaceuticals
    Toviaz | U.s. Pharmaceuticals
    No Recall

    Toviaz | U.s. Pharmaceuticals

    Toviaz | U.s. Pharmaceuticals

    The recommended starting dose of Toviaz is 4 mg once daily. Based upon individual response and tolerability, the dose may be increased to 8 mg once daily.

    The daily dose of Toviaz should not exceed 4 mg in the following populations:

    Patients with severe renal impairment (CLCR <30 mL/min). Patients taking potent CYP3A4 inhibitors, such as ketoconazole, itraconazole, and clarithromycin.

    Toviaz is not recommended for use in patients with severe hepatic impairment (Child-Pugh C) [see Warnings and Precautions (5.6, 5.8, 5.9); Use in Specific Populations (8.6, 8.7); and Drug Interactions (7.2)].

    Toviaz should be taken with liquid and swallowed whole. Toviaz can be administered with or without food, and should not be chewed, divided, or crushed.

Login To Your Free Account